TrialThe Journal of clinical endocrinology and metabolism2014

A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring.

Brian McNabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.